<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T00:37:12Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18882" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/18882</identifier><datestamp>2026-10-18T21:03:40Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Ankaferd® Kanama Durdurucunun Rat Abdominal Aort Kanama Modelinde Kanama Zamanına Etkisi</dc:title><dc:creator>ONK, ORUÇ ALPER</dc:creator><dc:creator>Erol, Huseyin Serkan</dc:creator><dc:creator>ONK, Didem</dc:creator><dc:creator>ÖZÇELİK, Fatih</dc:creator><dc:creator>YİĞİNER, Ömer</dc:creator><dc:creator>Aksüt, Mehmet</dc:creator><dc:creator>KAHRAMAN, ÜMİT</dc:creator><dc:creator>Sertoglu, Erdim</dc:creator><dc:creator>Tuncer, Osman Nuri</dc:creator><dc:creator>Erkut, Bilgehan</dc:creator><dc:subject>Periferik Damar Hastalıkları</dc:subject><dc:subject>Genel ve Dahili Tıp</dc:subject><dc:subject>Kalp ve Kalp Damar Sistemi</dc:subject><dc:subject>Cerrahi</dc:subject><dc:description>The use of topical haemostatic agents has been popularised in recent years in many areas of surgery. We aimed to determine whether Ankaferd blood stopper&amp;reg; (ABS) can shorten the bleeding time and decrease the amount of bleeding in a rat abdominal aortic bleeding modelPatients and Methods: A total of 40 rats were randomly divided into four groups (n= 10 in each group). Saline- and ABS-soaked gauzes were applied to rats that had not received any pre-treatment in Groups 1 and 2, while saline- and ABS-soaked gauzes were applied to rats that had received acetylsalicylic acid plus oral clopidrogel for 5 days in Groups 3 and 4. An incision of about 1 mm was made over the aorta just proximal to the iliac bifurcation. Mean bleeding time (MBT) and mean bleeding amount (MBA) were determined and compared. Results: There were no signifi cant differences in the age, weight and blood sample laboratory results of rats. Shorter MBT and less MBA were determined in ABS-soaked groups and the differences were statistically signifi cant. Conclusion: Ankaferd blood stopper&amp;reg; has the potential to reduce the bleeding time and post-operative blood loss after a major aortic surgery.</dc:description><dc:date>2016</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/18882</dc:identifier><dc:language>tr</dc:language><dc:relation>Koşuyolu Heart Journal</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/18882</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>